Quetiapine Extended Release (XR) for the Management of Psychotic Aggression or Agitation in Adult Acute Psychiatry
The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2009 by Bayside Health.
Recruitment status was Not yet recruiting
Recruitment status was Not yet recruiting
Sponsor:
Bayside Health
Collaborator:
AstraZeneca
Information provided by:
Bayside Health
ClinicalTrials.gov Identifier:
NCT00986167
First received: September 11, 2009
Last updated: September 28, 2009
Last verified: September 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is not yet open for participant recruitment. |
|---|---|
| Estimated Study Completion Date: | October 2010 |
| Estimated Primary Completion Date: | October 2010 (Final data collection date for primary outcome measure) |